Name in original language
راصد
Initiative overview
RASID is an artificial intelligence–based regulatory system developed by the Saudi Food and Drug Authority (SFDA) to support inspectors at border checkpoints in identifying controlled medicines carried by travelers. The system uses AI technologies to analyse images of medicine packages and automatically extract relevant information such as drug name, quantity, and dosage, and is designed to handle a wide variety of medicines across different brands, formulations, and packaging types.
The initiative addresses a key operational challenge in drug inspection processes, where inspectors previously relied on manual checks and personal expertise, leading to inconsistent decisions, longer processing times, and potential errors in identifying controlled substances. RASID reduces this dependency by providing a standardized, AI-driven approach that enhances accuracy and decision consistency.
Key features of the system include:
- Automated detection of controlled medicines using image analysis
- Comparison against official controlled substances lists
- Verification of prescriptions and medical reports
- Assessment of whether the quantity carried is reasonable based on medical need and duration of stay
- Real-time alerts for restricted or non-compliant medicines
By automating several manual inspection tasks, the system significantly improves operational efficiency, reduces reliance on individual experience, and ensures consistent regulatory decisions. During its pilot phase, the system demonstrated a significant reduction in inspection time and improved accuracy in identifying controlled medicines.
RASID also has strong potential for scalability and replication. The solution can be extended to other entry points, integrated with additional regulatory databases, and adapted for use in other government sectors or countries facing similar inspection challenges. It represents a scalable AI solution that enhances border inspection processes and supports public health protection.
RASID has been awarded the SDAIA “Aware” badge in recognition of its alignment with ethical AI principles and responsible AI practices. The initiative follows national guidelines for trustworthy artificial intelligence and demonstrates the commitment of the Saudi Food and Drug Authority (SFDA) to deploying AI systems that respect transparency, safety, and ethical standards while supporting regulatory operations and protecting public health.
